rs1172816 — BRSK1 BRSK1 Ovarian Reserve Variant

BRSK1 — The Kinase That Governs How Long Your Ovarian Clock Runs

Inside every follicle in the ovary, a delicate balance of kinase activity determines whether a dormant primordial oocyte survives or is irreversibly lost. BRSK1 — BR serine/threonine kinase 1 — is one of the molecular timekeepers in this system. Variants in BRSK1 are among the most robustly replicated genetic determinants of how long ovarian function is maintained, with population-level effects on menopause timing and individual-level effects on ovarian reserve measurable years before menopause arrives.

The Mechanism

BRSK1 is an AMP-activated protein kinase (AMPK)-related kinase¹¹ AMP-activated protein kinase (AMPK)-related kinase
Member of the AMPK superfamily, activated by the upstream kinase LKB1 via phosphorylation of Thr189 in the activation loop that is expressed at highest levels in neurons but also detectably in the ovary, pancreas, and other tissues. Its primary known functions are neuronal polarization, centrosome duplication, and — critically for ovarian biology — acting as a DNA damage checkpoint²² acting as a DNA damage checkpoint
BRSK1 phosphorylates WEE1, stabilizing it and thereby inhibiting CDK1 to prevent damaged cells from entering mitosis.

This DNA damage checkpoint role explains BRSK1's grip on the ovarian clock. Primordial follicles are kept dormant partly through active checkpoint signaling. When DNA damage occurs — whether from endogenous reactive oxygen species, replication errors, or exogenous exposures such as alkylating chemotherapy — BRSK1 participates in the decision of whether a follicle is repaired and preserved or marked for apoptotic elimination. Reduced BRSK1 checkpoint efficiency accelerates follicle loss.

The upstream activator of BRSK1, LKB1, also links it to energy sensing through the AMPK pathway. Deletion of LKB1 from mouse oocytes causes premature activation of the entire primordial follicle pool³³ causes premature activation of the entire primordial follicle pool
STK11/LKB1 deletion in oocytes leads to premature ovarian failure in mice, consistent with a model where the LKB1–BRSK1 axis maintains follicle quiescence.

rs1172816 is an intronic variant that sits in the same high-LD block as the functionally studied BRSK1 SNPs rs1172822 and rs11668344 (r²=0.88 between the latter two), and serves as a proxy marker for the same functional region.

The Evidence

The foundational discovery came from a GWAS of 2,979 European women⁴⁴ GWAS of 2,979 European women
Stolk et al. 2009 Nature Genetics GWAS identifying six loci for age at natural menopause including 19q13.4/BRSK1, which identified rs1172822 (19q13.4/BRSK1) with a per-T-allele effect of −0.4 years (P=6.3×10⁻¹¹) — one of the strongest-signal loci for menopause timing at the time. The locus has since been replicated across European, Chinese, and multi-ethnic cohorts.

The Chinese replication study linked the T allele to reduced serum AMH⁵⁵ linked the T allele to reduced serum AMH
He et al. 2013 PLOS One evaluating GWAS-identified SNPs for ANM in Chinese women (OR 3.15 for lowest-AMH tertile, P=0.008), a direct ovarian reserve measurement that precedes menopause by years to decades — connecting the GWAS signal to a practical biomarker of current fertility.

The most mechanistically informative study examined 1,141 female childhood cancer survivors⁶⁶ 1,141 female childhood cancer survivors
van Dorp et al. 2021 HR meta-analysis of three independent cohorts. Among those treated with high-dose alkylating agents (cyclophosphamide equivalent dose ≥8,000 mg/m²), the G allele of the LD-linked rs11668344 was associated with OR 5.00 for AG (95% CI 3.27–7.63) and OR 6.53 for GG (95% CI 2.36–18.05) for reduced ovarian function (P=3.0×10⁻⁴). The interpretation: reduced BRSK1 checkpoint efficiency makes follicles more vulnerable to DNA damage.

Practical Actions

The T allele's effect on ovarian reserve is modest (−0.4 years per allele in population terms) but becomes clinically meaningful when combined with lifestyle exposures that impose DNA damage on oocytes — smoking, alcohol, radiation, and environmental toxicants. Limiting these exposures directly addresses the BRSK1 mechanism. Serum AMH testing provides an individualized measure of current ovarian reserve and gives years of advance notice before fertility declines. For women planning delayed childbearing or facing chemotherapy, baseline AMH and antral follicle count establish a reference.

Anti-oxidant micronutrients — particularly CoQ10 (as ubiquinol), vitamin E, and N-acetylcysteine — support mitochondrial function in oocytes and reduce endogenous oxidative DNA damage, directly relevant to a variant that reduces checkpoint efficiency for DNA-damaged follicles.

Interactions

BRSK1 acts downstream of LKB1 (STK11), and upstream through WEE1 phosphorylation. Variants that increase endogenous DNA damage burden — such as null alleles in detoxification genes (GSTM1, GSTT1) or oxidative stress variants (SOD2) — could interact with reduced BRSK1 checkpoint efficiency to compound follicle attrition. These interactions have not been formally studied for rs1172816, but the pathway logic is biologically consistent.